Blog - CADDAC

05/10/2018 - CADDAC National Director

Patrick McKenna and Rick Green Lead the ADHD Awareness Charge

Patrick McKenna is on a mission to get the word out about ADHD: “People question the validity of ADHD because they can’t see the problem. If only those with ADHD could wear a bandage on their head 24/7 maybe people would not be so dismissive of ADHD sy

02/10/2018 - CADDAC National Director

During ADHD Awareness Month CADDAC Launches "ADHD Speaks" a National ADHD Awareness Campaign #ADHDSpeaks

Patrick McKenna and Other Canadian Celebrities Speak out About ADHD and Invite the Public to Join the Conversation #ADHD Speaks On October 2nd 2018 CADDAC, the Center for ADHD Awareness Canada, launched “ADHD Speaks” a multiyear national campaign to ge

18/07/2018 - CADDAC National Director

Digital Use and ADHD Symptoms

New research just published in the Journal of the American Medical Association is questioning whether heavy use of media platforms over time can increase the presentation of ADHD symptoms in adolescents. The study looked at the use of 14 different digi

11/07/2018 - CADDAC National Director

ADHD in Ontario Schools - Ontario Human Rights Commission Up-date

In February of 2017 I called the Ontario Human Right Commission asking for an up-date on ADHD in the Ontario school system and spoke with Ms. Cherie Robertson, Senior Policy Analyst Policy, Education, Monitoring & Outreach Ontario Human Rights Comm

04/07/2018 - CADDAC National Director

Disability Tax Credit Up-date

Over the past several months CADDAC has been receiving increased calls from families and individuals with ADHD upset that they have been denied the Disability Tax Credit (DTC). It seems to have become more difficult, if not impossible, for those with n

12/06/2018 - CADDAC National Director

Intuniv XR Coverage by Ontario Public Drug Program (OPDP)

CADDAC was just notified of the recommendation by the Committee to Evaluate Drugs or CED (part of OPDP) as a follow-up on our advocacy efforts to have Intuniv XR covered under the Ontario Public Drug Plan. The CED has recommended that Intuniv XR be rei